chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LOSS OF TASTE; WARM HEMOLYTIC ANEMIA; MEMORY LOSS; EYE SIGHT ISSUES; NO ENERGY; This spontaneous report received from a patient concerned a 74 year old male with unspecified race and ethnicity. The patient's weight was 165 pounds, and height was 71 inches. The patient's past medical history included alcohol use (1 beer or wine 3 times a month), and concurrent conditions included, hay fever, non smoker, allergy, non-alcoholic and prostrate cancer (since 2012). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: UNKNOWN) 1 total was administered to right arm on 07-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021 the patient experienced memory loss, eye sight issue, and felt tired with no energy. On MAY-2021 or JUN-2021, the patient diagnosed with warm hemolytic anemia. On an unspecified date, the patient experienced loss of taste. The patient was treated with steroids (prednisone) for 8 weeks, and On 18-AUG-2021, treatment medications included: Rituximab infusion (has had 4 infusions a week apart). Last infusion was on last Wednesday to the date of reporting (08-SEP-2021). Laboratory data (dates unspecified) included: Hemoglobin (NR: not provided) 7.8, 8.9 (units unspecified). The patient was still under physician care (oncologist and hematologist). The patient's autoimmune system had kicked in and is causing the adverse events, and his doctor cannot ruled out the vaccine as a causative agent.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from warm hemolytic anemia, and the outcome of memory loss, eye sight issues, loss of taste and no energy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210924336-Covid-19 vaccine ad26.cov2.s- Warm hemolytic anemia. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Red itchy rash about 1" wide by 2" long at injection site. No more pain other than sore arm 1 day post vaccination. Resolved within one week.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 08-AUG-2014 the patient was vaccinated with a dose of expired ZOSTAVAX (lot # H019998, expiration date 02-FEB-2014, dose not reported). Concomitant medications were not provided. The physician came on the phone and stated the expired ZOSTAVAX had no previous temperature excursions. No adverse symptoms were reported. Additional information has been requested.
Shingles infection. Blisters first appeared May 7 on my left shoulder.
Hives with sig. facial swelling Benadryl + Epinephrine given.
Neck pain near the top of the neck at the base of the skull slightly to the right of the center began around Feb 1. Began taking Ibuprofin, but it did not go away.  Thought I had muscle strain, but surprisingly there was no stiffness or loss of motion. Tried massage, heat, and cold packs with limited relief. Began interfering with sleep over the next few days. On the evening of Feb 4, I noticed a strange sensation on the right side of my tongue as if I was losing taste or feeling there. At 3 AM got out o bed due to neck pain and noticed right eye felt strange and was drooping. When I got up at 8 AM I saw eye droop and smile was only on one side of mouth. Called my doctor and was directed to an advice nurse who told me to go to the ER right away, since this could be a stroke or Bell's Palsy. Went to ER and was diagnosed as Bell's Palsy after blood tests, EKG, CT scan, and tests of limbs. Given medications and and released with prescriptions sent to CVS for prednisone and valacyclovir.
Strange swishing sound on her right ear; Arm got a little sore; This spontaneous case was reported by an other health care professional and describes the occurrence of TINNITUS (Strange swishing sound on her right ear) and PAIN IN EXTREMITY (Arm got a little sore) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     The patient's past medical history included Gallbladder disorder NOS (admitted in the ICU) in 2009 and Pancreatitis (admitted in the ICU) in 2009. Concurrent medical conditions included Type 1 diabetes mellitus (at 65 years old), Osteoarthritis, Hay fever and Fibromyalgia. Concomitant products included INSULIN for Type 1 diabetes mellitus.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced TINNITUS (Strange swishing sound on her right ear) and PAIN IN EXTREMITY (Arm got a little sore). At the time of the report, TINNITUS (Strange swishing sound on her right ear) and PAIN IN EXTREMITY (Arm got a little sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2009, Blood test: abnormal (abnormal) Pancreas is not producing insulin.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.  The 2nd dose was given on 04 May 2021 with lot number 008C21A.   This case was linked to MOD-2021-295852 (Patient Link).
Hep B dose #2 given 2 weeks after Hep B #1.
The day following immunization, upper arm became red, blistered, edematous, painful and lethargic.  Site observed on 10/27/11, had irregular area 3" X 1" at injection site that appeared crusted over, no longer swollen, red or warm to touch.  States it remains lethargic, told to contact PCP if remains that way.
On August 4, 2021, after going to the store with my husband and two of our grandchildren, I noticed I had trouble walking up the hills and had to stop and catch my breath because I had no energy.  I had my husband bring the vehicle to where I was sitting when we left to go home, rather than walk to our vehicle.  At home that evening, I couldn't wait to get out  of the shower to sit or lie down as my chest felt very weak.  I went to the ER the next day and was diagnosed with acute heart failure and later diagnosed with Takosubo, broken heart syndrome, where the upper part of my heart was not pumping blood.  I was put in ICU the Medical Center for two days, where they worked on getting my blood pressure back to normal.  They changed my blood pressure medications  (dropped furosemide to 5mg before bedtime if systolic number above 100; added Metropolol [Toprol]and added Spironolactone.   An Echocardiogram showed normal function of my heart on August 30, 2021.  I read where this syndrome corrects itself after a month or two with medical assistance.  I still have pinching in my heart occasionally.  I am afraid to get a COVID booster vaccine, which I am due for.  What is your advice????
Vaccine was administered SQ to the left arm at approximately 2:45pm. Mother called me at 415 pm stating pt was breaking out in bumps all over that are turning into hives. Mom states pt had similar reaction to a dose of polio prior.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 68-year-old female patient who received SHINGRIX (batch number 9349T, expiry date 7th September 2021) for prophylaxis. On 26th September 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were provided as follows: The pharmacist reported that the patient developed a rash after receiving SHINGRIX. The healthcare professional noted that the patient has been seeing a dermatologist for the rash.
No adverse event.   Wrong aged vaccination given.   Patient received Pfizer COVID 19 vaccine for 6 month to 4 years dosing instead of correct Pfizer COVID 19 vaccine for 5 - 11 years of age.
headache, sore arm, and swollen node(s) in the armpit of the same arm
This spontaneous report as received from a physician refers to a 52 year old patient. On 17-JUN-2013 the patient was vaccinated with ZOSTAVAX. On 17-JUN-2013 (reported as since 2 days ago) the patient experienced heart lump, itching, warm, redness  and swelling. The outcome of heart lump, itching, warm, redness,  and swelling is unknown. Additional information has been requested.
Fever 104 F, severe body aches, severe chills/shaking, headache - started at 10pm and progressively worsened. Fever broke at 10 am on 1/26/21. Other symptoms resolved by 1/28/21
Pain at injection site; Swelling at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0167) via an unspecified route of administration in the left arm on 07May2021 at 13:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN); all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 09:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient experienced pain and swelling at injection site which persisted for 5 days after injection. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events pain at injection site and swelling at injection site was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt received vaccines on 8/27/14 in preparation for a new baby. Came in 11/8/14 to make us aware that she had arm pain since she received the shots. She's been to a chiropractor w/o resolve. She's also used a heating pad.
This is in follow-up to report(s) previously submitted on 1/16/2007. Information has been received from a registered nurse concerning a 2 month old female who was born at 40 weeks gestation, with a normal delivery and no perinatal complications, who had a history of vomiting since she was two weeks old and a family history of a mother with a strong history of colic, severe reflux as a baby, and was always admitted to the hospital, who on 21 September 2006, was vaccinated with a first oral dose of Rotateq vaccine (human-bovine) (Lot# 653754/0139F). Concomitant vaccination administered on the same day included a dose of PEDVAXHIB. Concomitant therapy included PREVACID, 2.25 ml daily for gastroesophageal reflux, DONNATAL, 0.5 ml every six hours for colic and grape water for colic. There was no illness at the time of vaccination. About one week later, on 21 September 2006, it was reported that the patient developed rotavirus symptoms of diarrhea and vomiting and was admitted to the hospital on 28-SEP-2006. The patient was hospitalized for one day. Subsequently, the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a registered nurse via medical records indicated that the patient was seen on 21-SEP-2006 for a two month well child care visit. It was noted that the patient looked good, was not vomiting for a few days, and was doing well. Following the vaccinations with ROTATEQ and PEDVAXHIB the physician told her mother to give the patient TYLENOL. The patient's mother reported that the patient had been throwing up curdled formula every time she ate, though she had been moving her bowels and urinating okay. The physician changed the formula but she started vomiting more so the patient's mother changed it back, but the patient was still throwing up curdled formula. The patient was admitted to the hospital for observation on 28-SEP-2006 with vomiting, fussiness, and diarrhea. It was noted that the mother was young and overwhelmed with the vomiting of the baby for the past week and although there had been no weight loss for the patient, the mother was nervous because she herself had a history of similar symptoms when she was a baby. The physician planned to observe to see how many times the patient throws up, what she tolerates and her daily weight. The patient was discharged on 29-SEP-2006. It was reported that the patient recovered. Additional information is not expected.
No additional AE reported; an expired dose of PROQUAD was administered; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient of an unknown gender. The patient's medical history, concurrent conditions, concomitant medications and drug allergies were not reported.  On 24-FEB-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) 0,5 ml, lot # T029103 was confirmed to be valid, expiration date 23-FEB-2022 (expired product administered) (route of administration and injection site were not reported) for prophylaxis. No adverse events were reported.
Primary concern: broke out in extensive hives over torso, legs, and arms Also had: Fever of 100.4 or higher (may have been 101.4) Substantial fatigue and body aches  Went to Dr for hives, dr determined it was likely a vaccine reaction die to vaccine having occurred just prior to reaction.
Dizzy, muscular pain, fever, excessive sweating, upset stomach, feeling out of breath, fatigue
Patient received moderna vaccine on 2/10/21, 3/10/21, 11/22/21. Presented to ER on 7/21 for a fall.  On 7/27/22, prior to planned discharge, she was found to have a positive COVID-19 test. The facility could not accommodate at that time and she completed her isolation at the hospital. She continued to clinically improve and was found stable for discharge to facility from a medical standpoint on 8/11/22. COVID19 asymptomatic
Pt was administered a third dose of the covid vaccine in error. nursing home staff presented the patient to pharmacy staff as someone who needed a 'second dose'. Pt had already had a second dose (12/21/20, 1/11/21, 2/1/21). No adverse effects were reported. Error was discovered by pharmacy healthcare supervisor on 5/10/21.
Swollen lymph nodes, fever and malaise.; Fever; Malaise; This is a spontaneous report from a contactable healthcare professional (patient). A 44-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 02Mar2021 10:00 (Batch/Lot Number: EN6205) (at the age of 44 years) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included diabetes mellitus type 2 from an unknown date and unknown if ongoing. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL9264), dose 1, administered in Arm Left on 28Jan2021 11:00 (at the age of 44 years) for covid-19 immunisation. The patient's concomitant medication included metformin from unspecified date for unknown indication. The patient previously took penicillin and experienced hypersensitivity. The patient experienced swollen lymph nodes, fever and malaise on 02Mar2021 13:00 with outcome of not recovered without treatments. The patient underwent lab tests and procedures which included sars-cov-2 test negative: negative on 10Feb2021, sars-cov-2 test negative: negative   on 02Mar2021.  No follow-up attempts are needed. No further information is expected.
Diagnosed with AFIB 2 months after vaccine. Received a call from CDC requesting I fill this out
Eye blinking w/tic of head moving to the left; not accompanied by any other symptoms.  The tics have persisted especially when pt is tired.
Shivering; Fever of 101; Severe aches; Overall weakness and tiredness.
An 18 year old male received from healthcare professional on 8/22/05. An 18 year old male patient was diagnosed with viral meningitis 11 days after receiving the SC injection of Menomune, lot number U1656AC on 8/1/05. Site of administration was not reported. The patient was seen at a clinic for a fever of 103 F 8 days post immunization and was sent home. Treatment received was not reported. The patient returned to the hospital 3 days later and was admitted with a diagnosis of viral meningitis. The patient was discharged 2 days later. Recovery status was reported as not recovered.
When originally obtaining the vaccine, I had little side effect; the only thing I noticed was a slight fever for a few hours and a sore arm for a few days. 8 days after the shot was given, I developed a small swollen welt at the site of injection. I thought it may have been a mosquito bite, as I had spent the evening outside. That evening, I kept an eye on the swelling, and it was about the size of a half-dollar coin by the time I went to bed. When I woke up throughout the night (this is normal, as my sleeping patterns are irregular) I noticed more soreness in my arm. When I awoke for the day, the swelling had grown to be about the size of my hand. It is now sorer, and somewhat itchy, but I am managing with ibuprofen.
10/4/11 Client rec'd flu vaccine with incident (L) deltoid. 10/7/11 Client returned c/o sl fever day after vaccine, feels tired, body aches, both arms feel weak since vaccine (stated went jogging after vaccine given, daughter at home with nasal congestion). Client on TYLENOL/ referred to PMD BP 160/80 T 97.9.
Chest pain radiating to L shoulder and L side of back, SOB, pain when breathing needing 2 L of oxygen due to saturations at 64% with cyanosis, migraines.
Tired right after. Fever for a day. Slept a lot. Swelling at injection sight.
Information has been received from a 67 year old male with no relevant medical history or allergies who had been having both cosmetic dermatology work and periodontal work done for many years. On 18-AUG-2008 the patient was vaccinated with a dose of ZOSTAVAX (lot number 659410/0412X) (injection site and route not reported). Concomitant therapy included baby aspirin. Subsequently the patient and his physician as well noticed that he had been bleeding more during both procedures. Laboratory tests included blood work (results unspecified). Unspecified medical attention was sought. The outcome of the patient's experiences was unknown. No further information is available.
Vaccines given in same arm 12/20/08.  12/22/08 Rt arm w/2" area of erythema, ver tender, induration and tender distal deltoid, continue pain control, warm compresses, doubtful shot abscess.  Incidently, pt was treated for sinusitis and fever 12/22/08.  12/24/08, return followup, overall much better, rt arm with 3" area of erythema and tenderness distal to tip of deltoid.  Slight indurated.  First area of erythema medial arm 1/2 size it was 12/22.  Continued with pain relief and warm packs.  Will followup if increased size, swelling.  12/31/08  Spots where vaccines received still present.  Complains of pain with pressure.  3 cm mild erythema with 1 cm underlying freely movable mass on rt arm just anterior to axilla.  7 cm area of induration with mild erythema over rt deltoid.  Tx ibuprofen and benedryl, return if no improvement.  1/6/09 Update, better, still slightly swollen and tender with a lump on deltoid.  Tenderness much better.  Now on 1 benedryl, 2 motrin am/pm.  Arm painful when bumped.  Will continue motrin/benedryl BID for another week.
Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired). At the time of the report, FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       CONCOMINANT AND TREATMENT DRUGS WERE NOT USED. LAB DATA WAS NOT GIVEN.
Patient admitted through ER on 11/5/12. Patient with c/o paresthesias and increasing weakness in lower & upper extremities, also fever, chills, numbness.
Onset fever <24 hours after Td booster 102.4. Generalized hives 3 days later. No sxs other illness.
Approximately 24 hours after admin, Pts arm developed sore, red, inflamed rash- diagnosed at ER as allergic Rx.
Patient received Moderna as first dose accidentally as a 16 year old (off-label). We administered Moderna as second dose due to guidelines from the CDC website (off-label).
07/06/22 presents to ED for "syncope and abdominal pain" "COVID positive and has runny nose, sore throat, congestion, and cough" "no significant past medical history"
Patient felt dizzy, became pale and twisted his arm and sat on the floor. Recovered quickly after lying flat on floor, but felt tired, and had headache next day also had diarrhea.
dullness; tenderness; area looks hard and raised at injection site; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (dullness), TENDERNESS (tenderness), VACCINATION SITE INDURATION (area looks hard and raised at injection site) and VACCINATION SITE PAIN (Vaccination site pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (dullness), TENDERNESS (tenderness), VACCINATION SITE INDURATION (area looks hard and raised at injection site) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE REACTION (dullness), TENDERNESS (tenderness), VACCINATION SITE INDURATION (area looks hard and raised at injection site) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.            No concomitant medication was reported.  No treatment medication use was reported.  The patient has provided the vaccine facility center and declined the personal details.
Outside of left arm from shoulder to elbow was one huge hive that was hot to the touch for 7 days.
DIZZINESS, HEADACHE, NAUSEA, WEAKNESS, FATIGUE.
Patient presented to ED with weakness found to be Covid + and tachycardic.  Attended funeral and was exposed to a COVID+ person.  2 days laters she had runny nose and lost her sense of smell, developed tightness in her chest, nausea and headaches.  Feels very weak, lightheaded, short of breath, also has c/o fevers, denies chills or sweats.